Ascend Advanced Therapies is a total solutions gene therapy development partner, specializing in adeno-associated virus (AAV) development. The company has a global network of operational facilities and a team of experts with unparalleled insight and collaboration. They are committed to building the most flexible AAV platform and supporting customers from research through to commercialization.

www.ascend-adv.com

Ascend Advanced Therapies Group announced it raised $131 Million in an initial filing from an offering of $131 Million

Company Information

Related People

Funding Insights

Ascend Advanced Therapies Group announced it raised $131 Million in an initial filing from an offering of $131 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information